Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 41, Issue 3, 1991, Pages 179-186

  Out, Henk J ^a   Kooijman, Carole D ^a   Bruinse, Hein W ^a   Derksen, Ronald H W M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anti phospholipid antibody; Histopathology; Placenta; Systemic lupus erythematosus; Thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ARTICLE; CLINICAL ARTICLE; FEMALE; FETUS DEATH; HISTOLOGY; HUMAN; HUMAN TISSUE; LUPUS ERYTHEMATOSUS; PLACENTA; PRIORITY JOURNAL; THROMBOSIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; CARDIOLIPINS; FEMALE; FETAL DEATH; HUMAN; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHOSPHOLIPIDS; PLACENTA; PREGNANCY; SUPPORT, NON-U.S. GOV'T;

EID: 0025823651     PISSN: 00282243     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-2243(91)90021-C     Document Type: Article

References (27)

1. Anti-phospholipid antibodies: autoantibodies with a difference
2. Lupus anticoagulant: revival of an old phenomenon
3. Pathogenetic potential of anti-phospholipid antibodies
4. Anti-phospholipid antibodies in early repeated abortions: a case-controlled study
5. Anti-phospholipid antibodies in unselected patients with repeated abortion
6. Lupus anticoagulant, thrombosis and fetal loss
7. Fetal survival after prednisone suppression of maternal lupus-anticoagulant
8. Obstetric complications associated with the lupus anticoagulant
9. Heparin therapy of pregnant women with lupus anticoagulant or anti-cardiolipin antibodies
10. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus
11. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant
12. Immunological studies of the placenta in systemic lupus erythematosus
13. Placental abnormalities in systemic lupus erythematosus: in situ deposition of antinuclear antibodies
14. Decidual vasculopathy of the placenta in systemic lupus erythematosus
15. Placental lesions in maternal autoimmune diseases
16. Lupus pregnancy: a prospective study of placental changes
17. Drug treatment in pregnant women with anti-phospholipid antibodies: a preliminary report of a prospective study
18. The 1982 revised criteria for the classification of systemic lupus erythematosus
19. Coagulation screen is more specific than the anti-cardiolipin antibody ELISA in defining a thrombotic subset of lupus patients
20. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results
21. Anti-phospholipid antibodies
22. The surgical pathologist examines the placenta
23. Inhibition of protein C activation by endothelial cells in the presence of lupus anticagulant
24. Arterial thrombosis, intra-uterine death and ‘lupus’ anticoagulant: detection of immunoglobulin interfering with prostacyclin formation
25. Anti-phospholipid antibodies and recurrent pregnancy loss
26. Prostacyclin and thromboxane in gynecology and obstetrics